[Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control].

By Chaolin Huang, Ye-ming Wang, Xing-wang Li, L. Ren, Jianping Zhao, Y. Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu and 19 more. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2020

28,829 citations recorded by the source corpus.

Subfields: Emergency Medical Services, Infectious Diseases, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/f5fea5616003d6425e8a82338e6fd1efaccf2c85

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Emergency Medical Services

1. A. McMichael

In Infectious Diseases

1. Jun Zheng
2. Kwok-Yung Yuen
3. J. Chan
4. K. To
5. Yi-Wei Tang
6. Alexander Wong
7. Linda Wang
8. J. Shang

In Public Health, Environmental and Occupational Health

1. R. Liu
2. Xian-Tao Zeng
3. Alexander Wong
4. Alessandro Vespignani
5. Di Huang
6. Mark D. Griffiths
7. Scott Weaver
8. Torsten Bohn

Citations in the corpus

• Online Information Seeking and Disease Prevention Intent During COVID-19 Outbreak (2020, background): “…of studies have been promptly published in clinical research to advance knowledge regarding the epidemiological characteristics of COVID-19 (e.g., Huang et al., 2020; Wu et al., 2020; Zhu et al., 2020), the influence of this epidemic on how people seek and process related information to take…”
• A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 (2020, neutral): “Результаты Добавлено примечание ([1]): парциального”
• Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) (2020, background): “The emerging viral pathogen, severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)(1) has been reported in association with upper and lower respiratory tract infections ranging from asymptomatic to severe disease with fatal outcomes.(2) Recent reports have noted that anosmia, ageusia, ataxia,”
• Predictors of COVID-19 severity: A literature review (2020, background): “Evidence from multiple studies suggests that, compared to patients with mild COVID-19, patients with severe disease have lower granulocyte counts.(7,8,87,88) Further evidence also links the severity of COVID-19 to the degree of lymphopenia, in which blood lymphocyte percentage is inversely associate”
• In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (2020, methodology): “In some patients it has been reported that their immune response to the SARS-CoV-2 virus results in an increase of cytokines interleukin (IL)-6 and IL-10 [13, 28].”
• Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications (2020, neutral): “1016/S1473-3099(20)30141-9; pmid: 32113510”
• Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients (2021, background): “A series of studies have reported clinical characteristics of COVID-19 critical illness [7] and severe illness [8] patients.”
• The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence (2020, background): “Primitive symptoms of COVID-19 contain fever, dry cough, breathing difficulty, and boredom [4, 5].”